{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:09:10Z","timestamp":1790082550305,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112781","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T15:51:04Z","timestamp":1722009064000},"page":"112781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Unlocking milk thistle\u2019s anti-psoriatic potential in mice: Targeting PI3K\/AKT\/mTOR and KEAP1\/NRF2\/NF-\u03baB pathways to modulate inflammation and oxidative stress"],"prefix":"10.1016","volume":"139","author":[{"given":"Nada M.","family":"Kamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin A.M.","family":"El-Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina M.","family":"El-Kersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona M.","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112781_b0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin. Med. (northfield Il.)"},{"key":"10.1016\/j.intimp.2024.112781_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.intimp.2024.112781_b0015","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.intimp.2024.112781_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051219","article-title":"The PI3K\/Akt pathway: Emerging roles in skin homeostasis and a group of non-malignant skin disorders","volume":"10","author":"Teng","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.112781_b0025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112781_b0030","doi-asserted-by":"crossref","first-page":"665647","DOI":"10.3389\/fmed.2021.665647","article-title":"Recent updates on the involvement of PI3K\/AKT\/mTOR molecular cascade in the pathogenesis of hyperproliferative skin disorders","volume":"8","author":"Mercurio","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.intimp.2024.112781_b0035","first-page":"2319","article-title":"The Akt pathway in oncology therapy and beyond (Review)","volume":"53","author":"Nitulescu","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2024.112781_b0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112781_b0045","first-page":"854","article-title":"Upregulation of PI3K\/AKT\/mTOR, FABP5 and PPAR\u03b2\/\u03b4 in human psoriasis and imiquimod-induced murine psoriasiform dermatitis model","volume":"96","author":"Chamcheu","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.intimp.2024.112781_b0050","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1038\/cddis.2012.69","article-title":"Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis","volume":"3","author":"Madonna","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2024.112781_b0055","doi-asserted-by":"crossref","first-page":"1075804","DOI":"10.3389\/fimmu.2022.1075804","article-title":"Dual targeting of mTOR\/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation","volume":"13","author":"Roy","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112781_b0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/nyas.12059","article-title":"Role of PI3K\/Akt and mTOR complexes in Th17 cell differentiation","volume":"1280","author":"Nagai","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2024.112781_b0065","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1101\/gad.1662308","article-title":"Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK","volume":"22","author":"Dan","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.intimp.2024.112781_b0070","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2024.112781_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11071397","article-title":"The role of KEAP1-NRF2 system in atopic dermatitis and psoriasis","volume":"11","author":"Ogawa","year":"2022","journal-title":"Antioxidants."},{"key":"10.1016\/j.intimp.2024.112781_b0080","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bph.15983","article-title":"Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A","volume":"180","author":"Zhang","year":"2023","journal-title":"British Journal of Pharmacology."},{"key":"10.1016\/j.intimp.2024.112781_b0085","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3389\/fimmu.2019.01764","article-title":"Adaptive and innate immunity in psoriasis and other inflammatory disorders","volume":"10","author":"Sch\u00f6n","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112781_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116947","article-title":"GC-MS analysis and the effect of topical application of essential oils of Pinus canariensis C.Sm., Cupressus lusitanica Mill. and cupressus arizonica greene aerial parts in imiquimod-induced psoriasis in mice","volume":"318","author":"Kamal","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2024.112781_b0095","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2024.112781_b0100","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/ptr.6171","article-title":"Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases","volume":"32","author":"Abenavoli","year":"2018","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2024.112781_b0105","doi-asserted-by":"crossref","DOI":"10.1515\/jbcpp-2019-0206","article-title":"Silymarin: not just another antioxidant","volume":"31","author":"Camini","year":"2020","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112781_b0110","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/ptr.3207","article-title":"Milk thistle in liver diseases: past, present, future","volume":"24","author":"Abenavoli","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2024.112781_b0115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.etp.2010.04.009","article-title":"Anti-apoptotic and anti-inflammatory effects of Silybum marianum in treatment of experimental steatohepatitis","volume":"63","author":"Aghazadeh","year":"2011","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.intimp.2024.112781_b0120","unstructured":"United States Pharmacopeia (2023). Dietary Supplement Monographs, Powdered Milk Thistle Extract. USP-NF. Rockville, MD: United States Pharmacopeia."},{"key":"10.1016\/j.intimp.2024.112781_b0125","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.3390\/molecules27092996","article-title":"The essential oil derived from perilla frutescens (L.) britt. attenuates imiquimod–induced psoriasis-like skin lesions in BALB\/c mice","volume":"27","author":"Xu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.112781_b0130","article-title":"Antipsoriatic activity of oral and topical milk thistle extract against imiquimod-induced psoriasis-like skin lesions in balb\/c mice","volume":"4","author":"Al-mosawi","year":"2016","journal-title":"Journal of International Academic Research for Multidisciplinary"},{"key":"10.1016\/j.intimp.2024.112781_b0135","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1097\/j.pain.0000000000000674","article-title":"Mouse model of imiquimod-induced psoriatic itch","volume":"157","author":"Sakai","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.intimp.2024.112781_b0140","article-title":"The interplay of the inhibitory effect of nifuroxazide on NF-\u03baB\/STAT3 signaling attenuates acetic acid-induced ulcerative colitis in rats","volume":"79","author":"Yousra","year":"2020","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112781_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110696","article-title":"Luteolin attenuates imiquimod\u2013induced psoriasis-like skin lesions in BALB\/c mice via suppression of inflammation response","volume":"131","author":"Zhou","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.112781_b0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.intimp.2024.112781_b0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.intimp.2024.112781_b0160","series-title":"Handbook of histopathological and histochemical techniques: including museum techniques","author":"Culling","year":"2013"},{"key":"10.1016\/j.intimp.2024.112781_b0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1300\/J133v04n02_05","article-title":"HPLC-UV and LC-MS-MS characterization of silymarin in milk thistle seeds and corresponding products","volume":"4","author":"Wallace","year":"2003","journal-title":"Journal of Nutraceuticals, Functional & Medical Foods"},{"key":"10.1016\/j.intimp.2024.112781_b0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.chroma.2006.03.053","article-title":"Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography-electrospray tandem mass spectrometry","volume":"1116","author":"Lee","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.intimp.2024.112781_b0175","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00216-019-02274-3","article-title":"Liquid chromatography-drift tube ion mobility-mass spectrometry as a new challenging tool for the separation and characterization of silymarin flavonolignans","volume":"412","author":"Fenclova","year":"2020","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.intimp.2024.112781_b0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1039\/C4FO00834K","article-title":"Infusions of artichoke and milk thistle represent a good source of phenolic acids and flavonoids","volume":"6","author":"Pereira","year":"2015","journal-title":"Food Funct"},{"key":"10.1016\/j.intimp.2024.112781_b0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.indcrop.2015.12.023","article-title":"Phenolic profile and in vitro antioxidant power of different milk thistle [Silybum marianum (L.) Gaertn.] cultivars","volume":"83","author":"Lucini","year":"2016","journal-title":"Ind. Crop. Prod."},{"key":"10.1016\/j.intimp.2024.112781_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122582","article-title":"Tunisian milk thistle: an investigation of the chemical composition and the characterization of its cold-pressed seed oils","volume":"18","author":"Meddeb","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.intimp.2024.112781_b0195","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2174\/1381612825666190705192902","article-title":"Profile of fatty acids, tocopherols, phytosterols and polyphenols in mediterranean oils (argan oils, olive oils, milk thistle seed oils and nigella seed oil) and evaluation of their antioxidant and cytoprotective activities","volume":"25","author":"Zarrouk","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2024.112781_b0200","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/ijms20030739","article-title":"Advances in understanding the immunological pathways in psoriasis","volume":"20","author":"Georgescu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112781_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594735","article-title":"The IL-23\/IL-17 pathway in inflammatory skin diseases: from bench to bedside","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112781_b0210","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3889\/oamjms.2017.189","article-title":"Prevalence of oral mucosal lesions and their association with severity of psoriasis among psoriatic patients referred to dermatology clinic: a cross-sectional study in Kashan\/Iran","volume":"5","author":"Talaee","year":"2017","journal-title":"Open Access Macedonian Journal of Medical Sciences"},{"key":"10.1016\/j.intimp.2024.112781_b0215","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s00018-020-03726-1","article-title":"Immune responses and therapeutic options in psoriasis","volume":"78","author":"Afonina","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2024.112781_b0220","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/molecules27030591","article-title":"Promising strategies in plant-derived treatments of psoriasis-update of in vitro, in vivo, and clinical trials studies","volume":"27","author":"Nowak-Perlak","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.112781_b0225","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3390\/ijms20102558","article-title":"Apoptotic or antiproliferative activity of natural products against keratinocytes for the treatment of psoriasis","volume":"20","author":"Huang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112781_b0230","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2174\/0929867323666160321121819","article-title":"Anti-psoriasis agents from natural plant sources","volume":"23","author":"Bonesi","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2024.112781_b0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ctcp.2018.01.007","article-title":"Management of psoriasis with nutraceuticals: An update","volume":"31","author":"Raut","year":"2018","journal-title":"Complement. Ther. Clin. Pract."},{"key":"10.1016\/j.intimp.2024.112781_b0240","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/ptr.6973","article-title":"Potential herbal constituents for psoriasis treatment as protective and effective therapy","volume":"35","author":"Dabholkar","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2024.112781_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100175","article-title":"Targeting TGF-\u03b21\/miR-21 pathway in keratinocytes reveals protective effects of silymarin on imiquimod-induced psoriasis mouse model","volume":"3","author":"Henriet","year":"2023","journal-title":"JID Innovations"},{"key":"10.1016\/j.intimp.2024.112781_b0250","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.3389\/fimmu.2018.02786","article-title":"Epidermal mTORC1 signaling contributes to the pathogenesis of psoriasis and could serve as a therapeutic target","volume":"9","author":"Buerger","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112781_b0255","doi-asserted-by":"crossref","first-page":"e0180853","DOI":"10.1371\/journal.pone.0180853","article-title":"Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation","volume":"12","author":"Buerger","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112781_b0260","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41401-019-0272-2","article-title":"Crosstalk between the Akt\/mTORC1 and NF-\u03baB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs","volume":"40","author":"Li","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2024.112781_b0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12551-016-0244-4","article-title":"The Keap1\u2013Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases","volume":"9","author":"Deshmukh","year":"2017","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.intimp.2024.112781_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153755","article-title":"Targeting Nrf2\/Keap1 signaling pathway by bioactive natural agents: Possible therapeutic strategy to combat liver disease","volume":"92","author":"Jayasuriya","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2024.112781_b0275","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000475890","article-title":"Targeting the KEAP1-NRF2 system to prevent kidney disease progression","volume":"45","author":"Nezu","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.intimp.2024.112781_b0280","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ajpath.2019.10.022","article-title":"Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates epidermal keratinization under psoriatic skin inflammation","volume":"190","author":"Ogawa","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2024.112781_b0285","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2019.09.003","article-title":"Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR\/\u03b2-TrcP\/Nrf2 pathway","volume":"145","author":"Qiao","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2024.112781_b0290","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BST20150014","article-title":"Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways","volume":"43","author":"Wardyn","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.intimp.2024.112781_b0295","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cellsig.2011.01.014","article-title":"Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway","volume":"23","author":"Yu","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2024.112781_b0300","doi-asserted-by":"crossref","first-page":"1240433","DOI":"10.3389\/fphar.2023.1240433","article-title":"Nrf2-mediated therapeutic effects of dietary flavones in different diseases","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112781_b0305","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/jdv.14433","article-title":"The role of IL-23 and the IL-23\/TH 17 immune axis in the pathogenesis and treatment of psoriasis","volume":"31","author":"Girolomoni","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.intimp.2024.112781_b0310","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"Lowes","year":"2014","journal-title":"Immunology of Psoriasis. Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2024.112781_b0315","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1074\/jbc.M207577200","article-title":"Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17","volume":"278","author":"Aggarwal","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2024.112781_b0320","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.immuni.2012.04.010","article-title":"The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury","volume":"37","author":"Lai","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.112781_b0325","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0625.2011.01412.x","article-title":"IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion","volume":"21","author":"Gutowska-Owsiak","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2024.112781_b0330","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.112781_b0335","first-page":"4390","article-title":"mTOR mediates IL-23 induction of neutrophil IL-17 and IL-22","volume":"196","author":"Chen","year":"2016","journal-title":"Production"},{"key":"10.1016\/j.intimp.2024.112781_b0340","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.3390\/ijms21176206","article-title":"Oxidative stress as an important contributor to the pathogenesis of psoriasis","volume":"21","author":"Ple\u0144kowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112781_b0345","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative stress: harms and benefits for human health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2024.112781_b0350","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0891-5849(02)00826-2","article-title":"Free radical-induced damage to DNA: mechanisms and measurement","volume":"32","author":"Dizdaroglu","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2024.112781_b0355","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/antiox11020282","article-title":"The involvement of oxidative stress in psoriasis: A systematic review","volume":"11","author":"Dobric\u0103","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.intimp.2024.112781_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112024","article-title":"Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer","volume":"142","author":"Fallah","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.112781_b0365","doi-asserted-by":"crossref","DOI":"10.1515\/biol-2015-0017","article-title":"Antioxidant and hepatoprotective activity of milk thistle (Silybum marianum L Gaertn.) seed oil","volume":"10","author":"Hermenean","year":"2015","journal-title":"Open Life Sciences"},{"key":"10.1016\/j.intimp.2024.112781_b0370","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s12276-022-00829-6","article-title":"The Nrf2 antioxidant defense system in intervertebral disc degeneration: Molecular insights","volume":"54","author":"Xiang","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2024.112781_b0375","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1021\/acs.jafc.9b06882","article-title":"Lycopene prevents DEHP-induced Leydig cell damage with the Nrf2 antioxidant signaling pathway in mice","volume":"68","author":"Zhao","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.intimp.2024.112781_b0380","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbagen.2014.11.021","article-title":"Nrf2 regulates ROS production by mitochondria and NADPH oxidase","volume":"1850","author":"Kovac","year":"2015","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.intimp.2024.112781_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172620","article-title":"Novel repair mechanisms in a renal ischaemia\/reperfusion model: Subsequent saxagliptin treatment modulates the pro-angiogenic GLP-1\/cAMP\/VEGF, ANP\/eNOS\/NO, SDF-1\u03b1\/CXCR4, and Kim-1\/STAT3\/HIF-1\u03b1\/VEGF\/eNOS pathways","volume":"861","author":"Kamel","year":"2019","journal-title":"Eur. J. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692401302X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692401302X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T08:09:19Z","timestamp":1732954159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692401302X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":77,"alternative-id":["S156757692401302X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112781","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking milk thistle\u2019s anti-psoriatic potential in mice: Targeting PI3K\/AKT\/mTOR and KEAP1\/NRF2\/NF-\u03baB pathways to modulate inflammation and oxidative stress","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112781"}}